Preclinical data demonstrates unique binding location of CT-95 on mesothelin and avoidance of binding to shed mesothelin Data supports ongoing Phase 1 clinical trial for CT-95

The transaction includes the acquisition of Jeffs' Brands' wholly-owned subsidiary, Smart Repair Pro, and its approximately 49.1% ownership interest in SciSparc Nutraceutical Inc. by a Canadian public company in exchange for an up to 90% equity interest ( on a fully diluted basis ) in such ...

SP-26 showed safe, sustained ketamine release in minipigs with no adverse events and consistent plasma levels for up to 22 days. Silo Pharma's SP-26 met all preclinical endpoints and aims to qualify for the FDA's streamlined 505 ( b ) ( 2 ) pathway. Don't face extreme market conditions ...

If you need your Social Security check to be as large as possible, you should avoid doing these three things.

Highlights ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler raised Visa Inc. V price target from $383 to $384.

The world of crypto trading is undergoing a seismic transformation. What was once a volatile, sentiment-driven market is increasingly governed by machine learning models, sentiment analytics, and AI-optimized strategies. In 2025, the future of crypto isn't just decentralized it's automated.

LEXINGTON, Mass., April 30, 2025 ( GLOBE NEWSWIRE ) -- Constant Therapy Health, a pioneer in clinically proven digital AI-driven speech, language, and cognitive therapy, announces a significant expansion to its product offerings.

Eric Trump, executive vice president of the Trump Organization and the younger son of President Donald Trump, criticized the current financial system as outdated and inefficient, suggesting that cryptocurrency offers a faster and more cost-effective alternative.

UAB "Atsinaujinančios energetikos investicijos" ( the Company ) publishes its factsheet, providing information about the Company's investment portfolio, key events, business strategy, operating segments, and financial indicators as of 31 March 2025.